March 24, 2023
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen shares jump after company announces buyback plan and long-term projections


Thousand Oaks-based Amgen, one of the largest biotechnology companies in the world, issued fiscal guidance for 2022 on Feb. 8 and shared plans to repurchase $6 billion of its shares in the first quarter of this year. In fiscal year 2022, Amgen expects revenue to be between $25.4 and $26.5 billion, with non-GAAP earnings per…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.